Purification of HCC-specific extracellular vesicles on nanosubstrates for early HCC detection by digital scoring.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
07 09 2020
Historique:
received: 13 12 2019
accepted: 06 08 2020
entrez: 8 9 2020
pubmed: 9 9 2020
medline: 2 10 2020
Statut: epublish

Résumé

We report a covalent chemistry-based hepatocellular carcinoma (HCC)-specific extracellular vesicle (EV) purification system for early detection of HCC by performing digital scoring on the purified EVs. Earlier detection of HCC creates more opportunities for curative therapeutic interventions. EVs are present in circulation at relatively early stages of disease, providing potential opportunities for HCC early detection. We develop an HCC EV purification system (i.e., EV Click Chips) by synergistically integrating covalent chemistry-mediated EV capture/release, multimarker antibody cocktails, nanostructured substrates, and microfluidic chaotic mixers. We then explore the translational potential of EV Click Chips using 158 plasma samples of HCC patients and control cohorts. The purified HCC EVs are subjected to reverse-transcription droplet digital PCR for quantification of 10 HCC-specific mRNA markers and computation of digital scoring. The HCC EV-derived molecular signatures exhibit great potential for noninvasive early detection of HCC from at-risk cirrhotic patients with an area under receiver operator characteristic curve of 0.93 (95% CI, 0.86 to 1.00; sensitivity = 94.4%, specificity = 88.5%).

Identifiants

pubmed: 32895384
doi: 10.1038/s41467-020-18311-0
pii: 10.1038/s41467-020-18311-0
pmc: PMC7477161
doi:

Substances chimiques

Biomarkers, Tumor 0
Dimethylpolysiloxanes 0
RNA, Messenger 0
baysilon 63148-62-9

Types de publication

Journal Article Observational Study Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Validation Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

4489

Subventions

Organisme : NCI NIH HHS
ID : R01 CA246329
Pays : United States
Organisme : NCI NIH HHS
ID : U01 CA230705
Pays : United States
Organisme : NCI NIH HHS
ID : R21 CA216807
Pays : United States
Organisme : NIBIB NIH HHS
ID : U01 EB026421
Pays : United States
Organisme : NCI NIH HHS
ID : U01 CA198900
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA218356
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA016042
Pays : United States
Organisme : NCI NIH HHS
ID : R21 CA235340
Pays : United States
Organisme : NCI NIH HHS
ID : P01 CA233452
Pays : United States
Organisme : NCI NIH HHS
ID : R21 CA240887
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA253651
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA246304
Pays : United States

Références

Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A. & Jemal, A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 68, 394–424 (2018).
Tsuchiya, N., Sawada, Y., Endo, I., Saito, K., Uemura, Y. & Nakatsura, T. Biomarkers for the early diagnosis of hepatocellular carcinoma. World J. Gastroenterol. 21, 10573–10583 (2015).
pubmed: 26457017 pmcid: 4588079
Marrero, J. A. et al. Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the American Association for the Study of Liver Diseases. Hepatology 68, 723–750 (2018).
Forner, A. & Bruix, J. Biomarkers for early diagnosis of hepatocellular carcinoma. Lancet Oncol. 13, 750–751 (2012).
pubmed: 22738800
Heitzer, E., Haque, I. S., Roberts, C. E. S. & Speicher, M. R. Current and future perspectives of liquid biopsies in genomics-driven oncology. Nat. Rev. Genet. 20, 71–88 (2019).
pubmed: 30410101
Siravegna, G., Marsoni, S., Siena, S. & Bardelli, A. Integrating liquid biopsies into the management of cancer. Nat. Rev. Clin. Oncol. 14, 531–548 (2017).
pubmed: 28252003
Krebs, M. G., Metcalf, R. L., Carter, L., Brady, G., Blackhall, F. H. & Dive, C. Molecular analysis of circulating tumour cells-biology and biomarkers. Nat. Rev. Clin. Oncol. 11, 129–144 (2014).
pubmed: 24445517
Chen, J. F. et al. Clinical applications of NanoVelcro rare-cell assays for detection and characterization of circulating tumor cells. Theranostics 6, 1425–1439 (2016).
pubmed: 27375790 pmcid: 4924510
Dong, J. et al. Nanostructured substrates for detection and characterization of circulating rare cells: from materials research to clinical applications. Adv. Mater. 32, 1903663 (2020).
Cristiano, S. et al. Genome-wide cell-free DNA fragmentation in patients with cancer. Nature 570, 385–389 (2019).
pubmed: 31142840 pmcid: 6774252
Shen, S. Y. et al. Sensitive tumour detection and classification using plasma cell-free DNA methylomes. Nature 563, 579–583 (2018).
pubmed: 30429608
Kosaka, N. et al. Exploiting the message from cancer: the diagnostic value of extracellular vesicles for clinical applications. Exp. Mol. Med. 51, 31 (2019).
pmcid: 6418231
van Niel, G., D’Angelo, G. & Raposo, G. Shedding light on the cell biology of extracellular vesicles. Nat. Rev. Mol. Cell Biol. 19, 213–228 (2018).
pubmed: 29339798
Raposo, G. & Stahl, P. D. Extracellular vesicles: a new communication paradigm? Nat. Rev. Mol. Cell Biol. 20, 509–510 (2019).
pubmed: 31324871
Rahbarghazi, R. et al. Tumor-derived extracellular vesicles: reliable tools for Cancer diagnosis and clinical applications. Cell Commun. Signal. 17, 73 (2019).
pubmed: 31291956 pmcid: 6617682
Livshits, M. A. et al. Isolation of exosomes by differential centrifugation: Theoretical analysis of a commonly used protocol. Sci. Rep. 5, 17319 (2015).
pubmed: 26616523
Davies, R. T., Kim, J., Jang, S. C., Choi, E. J., Gho, Y. S. & Park, J. Microfluidic filtration system to isolate extracellular vesicles from blood. Lab Chip 12, 5202–5210 (2012).
pubmed: 23111789
Kanwar, S. S., Dunlay, C. J., Simeone, D. M. & Nagrath, S. Microfluidic device (ExoChip) for on-chip isolation, quantification and characterization of circulating exosomes. Lab Chip 14, 1891–1900 (2014).
pubmed: 24722878 pmcid: 4134440
Zhao, Z., Yang, Y., Zeng, Y. & He, M. A microfluidic ExoSearch chip for multiplexed exosome detection towards blood-based ovarian cancer diagnosis. Lab Chip 16, 489–496 (2016).
pubmed: 26645590 pmcid: 4729647
Yang, F., Liao, X., Tian, Y. & Li, G. Exosome separation using microfluidic systems: size-based, immunoaffinity-based and dynamic methodologies. Biotechnol. J. 12, 1600699 (2017).
Wang, Z. et al. Ciliated micropillars for the microfluidic-based isolation of nanoscale lipid vesicles. Lab Chip 13, 2879–2882 (2013).
pubmed: 23743667 pmcid: 3740541
Wunsch, B. H. et al. Nanoscale lateral displacement arrays for the separation of exosomes and colloids down to 20 nm. Nat. Nanotechnol. 11, 936–940 (2016).
pubmed: 27479757
Reategui, E. et al. Engineered nanointerfaces for microfluidic isolation and molecular profiling of tumor-specific extracellular vesicles. Nat. Commun. 9, 175 (2018).
pubmed: 29330365 pmcid: 5766611
Dong, J. et al. Bio-inspired NanoVilli Chips for enhanced capture of tumor-derived extracellular vesicles: toward non-invasive detection of gene alterations in non-small cell lung cancer. ACS Appl. Mater. Interfaces 11, 13973–13983 (2019).
pubmed: 30892008 pmcid: 6545291
Melo, S. A. et al. Glypican-1 identifies cancer exosomes and detects early pancreatic cancer. Nature 523, 177–182 (2015).
pubmed: 26106858 pmcid: 4825698
Zhang, P. et al. Ultrasensitive detection of circulating exosomes with a 3D-nanopatterned microfluidic chip. Nat. Biomed. Eng. 3, 438–451 (2019).
pubmed: 31123323 pmcid: 6556143
Wang, X. et al. Extracellular mRNA detected by molecular beacons in tethered lipoplex nanoparticles for diagnosis of human hepatocellular carcinoma. PLoS ONE 13, e0198552 (2018).
pubmed: 29879168 pmcid: 5991670
Zhai, W. et al. The spatial organization of intra-tumour heterogeneity and evolutionary trajectories of metastases in hepatocellular carcinoma. Nat. Commun. 8, 4565 (2017).
pubmed: 28240289 pmcid: 5333358
Hirschfield, H. et al. In vitro modeling of hepatocellular carcinoma molecular subtypes for anti-cancer drug assessment. Exp. Mol. Med. 50, e419 (2018).
pubmed: 29303513 pmcid: 5992986
Liu, J. P., Dang, H. & Wang, X. W. The significance of intertumor and intratumor heterogeneity in liver cancer. Exp. Mol. Med. 50, e416 (2018).
pubmed: 29303512 pmcid: 5992990
Court, C. M. et al. A novel multimarker assay for the phenotypic profiling of circulating tumor cells in hepatocellular carcinoma. Liver Transpl. 24, 946–960 (2018).
pubmed: 29624843 pmcid: 6097911
Wang, S. et al. Three-dimensional nanostructured substrates toward efficient capture of circulating tumor cells. Angew. Chem. Int. Ed. 48, 8970–8973 (2009).
Stroock, A. D., Dertinger, S. K., Ajdari, A., Mezic, I., Stone, H. A. & Whitesides, G. M. Chaotic mixer for microchannels. Science 295, 647–651 (2002).
pubmed: 11809963
Kolb, H. C., Finn, M. G. & Sharpless, K. B. Click chemistry: diverse chemical function from a few good reactions. Angew. Chem. Int. Ed. 40, 2004–2021 (2001).
Witt, D. Recent developments in disulfide bond formation. Synthesis, 2491–2509 (2008).
Wang, S. et al. Highly efficient capture of circulating tumor cells by using nanostructured silicon substrates with integrated chaotic micromixers. Angew. Chem. Int. Ed. 50, 3084–3088 (2011).
Blackman, M. L., Royzen, M. & Fox, J. M. Tetrazine ligation: fast bioconjugation based on inverse-electron-demand Diels-Alder reactivity. J. Am. Chem. Soc. 130, 13518–13519 (2008).
pubmed: 18798613 pmcid: 2653060
Smith, E. A., Wanat, M. J., Cheng, Y. F., Barreira, S. V. P., Frutos, A. G. & Corn, R. M. Formation, spectroscopic characterization, and application of sulfhydryl-terminated alkanethiol monolayers for the chemical attachment of DNA onto gold surfaces. Langmuir 17, 2502–2507 (2001).
Kalinich, M. et al. An RNA-based signature enables high specificity detection of circulating tumor cells in hepatocellular carcinoma. Proc. Natl Acad. Sci. USA 114, 1123–1128 (2017).
pubmed: 28096363
Dong, J. et al. Covalent chemistry on nanostructured substrates enables noninvasive quantification of gene rearrangements in circulating tumor cells. Sci. Adv. 5, eaav9186 (2019).
pubmed: 31392269 pmcid: 6669017
Wang, S. T. et al. Highly efficient capture of circulating tumor cells by using nanostructured silicon substrates with integrated chaotic micromixers. Angew. Chem. Int. Ed. 50, 3084–3088 (2011).
Sheng, W. et al. Capture, release and culture of circulating tumor cells from pancreatic cancer patients using an enhanced mixing chip. Lab Chip 14, 89–98 (2014).
pubmed: 24220648
Thery, C., Amigorena, S., Raposo, G. & Clayton, A. Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Curr. Protoc. Cell. Biol. 10.1002/0471143030.cb0322s30 (2006).
Tauro, B. J. et al. Comparison of ultracentrifugation, density gradient separation, and immunoaffinity capture methods for isolating human colon cancer cell line LIM1863-derived exosomes. Methods 56, 293–304 (2012).
pubmed: 22285593
Willms, A. et al. Tumour-associated circulating microparticles: A novel liquid biopsy tool for screening and therapy monitoring of colorectal carcinoma and other epithelial neoplasia. Oncotarget 7, 30867–30875 (2016).
pubmed: 27127176 pmcid: 5058724
Julich-Haertel, H. et al. Cancer-associated circulating large extracellular vesicles in cholangiocarcinoma and hepatocellular carcinoma. J. Hepatol. 67, 282–292 (2017).
pubmed: 28267620
Mathivanan, S., Fahner, C. J., Reid, G. E. & Simpson, R. J. ExoCarta 2012: database of exosomal proteins, RNA and lipids. Nucleic Acids Res. 40, D1241–D1244 (2012).
pubmed: 21989406
Pathan, M. et al. Vesiclepedia 2019: a compendium of RNA, proteins, lipids and metabolites in extracellular vesicles. Nucleic Acids Res. 47, D516–D519 (2019).
pubmed: 30395310
Manier, S. et al. Whole-exome sequencing of cell-free DNA and circulating tumor cells in multiple myeloma. Nat. Commun. 9, 1691 (2018).
pubmed: 29703982 pmcid: 5923255
Enderle, D. et al. Characterization of RNA from exosomes and other extracellular vesicles isolated by a novel spin column-based method. PLoS ONE 10, e0136133 (2015).
pubmed: 26317354 pmcid: 4552735
Llovet, J. M., Bru, C. & Bruix, J. Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin. Liver Dis. 19, 329–338 (1999).
pubmed: 10518312
Mazzaferro, V. et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N. Engl. J. Med. 334, 693–699 (1996).
pubmed: 8594428
Yao, F. Y. et al. Downstaging of hepatocellular cancer before liver transplant: long-term outcome compared to tumors within Milan criteria. Hepatology 61, 1968–1977 (2015).
pubmed: 25689978 pmcid: 4809192
Levine, D. M. et al. Pathway and gene-set activation measurement from mRNA expression data: the tissue distribution of human pathways. Genome Biol. 7, R93 (2006).
pubmed: 17044931 pmcid: 1794557
Zhang, D. Y. & Friedman, S. L. Fibrosis-dependent mechanisms of hepatocarcinogenesis. Hepatology 56, 769–775 (2012).
pubmed: 22378017 pmcid: 4087159
Blackman, M. L., Royzen, M. & Fox, J. M. Tetrazine ligation: fast bioconjugation based on inverse-electron-demand Diels-Alder reactivity. J. Am. Chem. Soc. 130, 13518–13519 (2008).
pubmed: 18798613 pmcid: 2653060
Karver, M. R., Weissleder, R. & Hilderbrand, S. A. Synthesis and evaluation of a series of 1,2,4,5-tetrazines for bioorthogonal conjugation. Bioconjug. Chem. 22, 2263–2270 (2011).
pubmed: 21950520 pmcid: 3254257
Xu, R. H. et al. Circulating tumour DNA methylation markers for diagnosis and prognosis of hepatocellular carcinoma. Nat. Mater. 16, 1155–1161 (2017).
pubmed: 29035356
ChienJen Chen et al. Risk of Hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA 295, 65–73 (2006).
pubmed: 16391218
Peng, K. Q., Yan, Y. J., Gao, S. P. & Zhu, J. Synthesis of large-area silicon nanowire arrays via self-assembling nanoelectrochemistry. Adv. Mater. 14, 1164–1167 (2002).
Huang, X. et al. Characterization of human plasma-derived exosomal RNAs by deep sequencing. BMC Genomics 14, 319 (2013).
pubmed: 23663360 pmcid: 3653748
Wan, Y. et al. Rapid magnetic isolation of extracellular vesicles via lipid-based nanoprobes. Nat. Biomed. Eng. 1, 0058 (2017).
pubmed: 28966872 pmcid: 5618714

Auteurs

Na Sun (N)

California NanoSystems Institute, Crump Institute for Molecular Imaging, Department of Molecular and Medical Pharmacology, University of California, Los Angeles, CA, 90095, USA.
Key Laboratory for Nano-Bio Interface, Suzhou Institute of Nano-Tech and Nano-Bionics, University of Chinese Academy of Sciences, Chinese Academy of Sciences, 215123, Suzhou, P.R. China.

Yi-Te Lee (YT)

California NanoSystems Institute, Crump Institute for Molecular Imaging, Department of Molecular and Medical Pharmacology, University of California, Los Angeles, CA, 90095, USA.

Ryan Y Zhang (RY)

California NanoSystems Institute, Crump Institute for Molecular Imaging, Department of Molecular and Medical Pharmacology, University of California, Los Angeles, CA, 90095, USA.

Rueihung Kao (R)

California NanoSystems Institute, Crump Institute for Molecular Imaging, Department of Molecular and Medical Pharmacology, University of California, Los Angeles, CA, 90095, USA.

Pai-Chi Teng (PC)

Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, 90048, USA.

Yingying Yang (Y)

Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA, 90095, USA.

Peng Yang (P)

California NanoSystems Institute, Crump Institute for Molecular Imaging, Department of Molecular and Medical Pharmacology, University of California, Los Angeles, CA, 90095, USA.

Jasmine J Wang (JJ)

Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, 90048, USA.

Matthew Smalley (M)

California NanoSystems Institute, Crump Institute for Molecular Imaging, Department of Molecular and Medical Pharmacology, University of California, Los Angeles, CA, 90095, USA.

Pin-Jung Chen (PJ)

California NanoSystems Institute, Crump Institute for Molecular Imaging, Department of Molecular and Medical Pharmacology, University of California, Los Angeles, CA, 90095, USA.

Minhyung Kim (M)

Division of Cancer Biology and Therapeutics, Departments of Surgery, Cedars-Sinai Medical Center, Los Angeles, CA, 90048, USA.

Shih-Jie Chou (SJ)

California NanoSystems Institute, Crump Institute for Molecular Imaging, Department of Molecular and Medical Pharmacology, University of California, Los Angeles, CA, 90095, USA.

Lirong Bao (L)

California NanoSystems Institute, Crump Institute for Molecular Imaging, Department of Molecular and Medical Pharmacology, University of California, Los Angeles, CA, 90095, USA.

Jing Wang (J)

California NanoSystems Institute, Crump Institute for Molecular Imaging, Department of Molecular and Medical Pharmacology, University of California, Los Angeles, CA, 90095, USA.

Xinyue Zhang (X)

California NanoSystems Institute, Crump Institute for Molecular Imaging, Department of Molecular and Medical Pharmacology, University of California, Los Angeles, CA, 90095, USA.

Dongping Qi (D)

California NanoSystems Institute, Crump Institute for Molecular Imaging, Department of Molecular and Medical Pharmacology, University of California, Los Angeles, CA, 90095, USA.

Juvelyn Palomique (J)

Comprehensive Transplant Center, Cedars-Sinai Medical Center, Los Angeles, CA, 90048, USA.

Nicolas Nissen (N)

Comprehensive Transplant Center, Cedars-Sinai Medical Center, Los Angeles, CA, 90048, USA.

Steven-Huy B Han (SB)

Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA, 90095, USA.

Saeed Sadeghi (S)

Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA, 90095, USA.
Department of Surgery, David Geffen School of Medicine, University of California, Los Angeles, CA, 90095, USA.

Richard S Finn (RS)

Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA, 90095, USA.
Department of Surgery, David Geffen School of Medicine, University of California, Los Angeles, CA, 90095, USA.

Sammy Saab (S)

Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA, 90095, USA.

Ronald W Busuttil (RW)

Department of Surgery, David Geffen School of Medicine, University of California, Los Angeles, CA, 90095, USA.
Jonsson Comprehensive Cancer Center, University of California, Los Angeles, CA, 90095, USA.

Daniela Markovic (D)

Department of Medicine, Statistics Core, David Geffen School of Medicine, University of California, Los Angeles, CA, 90095, USA.

David Elashoff (D)

Department of Medicine, Statistics Core, David Geffen School of Medicine, University of California, Los Angeles, CA, 90095, USA.

Hsiao-Hua Yu (HH)

Smart Organic Materials Laboratory, Institute of Chemistry, Academia Sinica, 11529, Taipei, Taiwan.

Huiying Li (H)

California NanoSystems Institute, Crump Institute for Molecular Imaging, Department of Molecular and Medical Pharmacology, University of California, Los Angeles, CA, 90095, USA.

Anthony P Heaney (AP)

Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA, 90095, USA.

Edwin Posadas (E)

Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, 90048, USA.

Sungyong You (S)

Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, 90048, USA.
Division of Cancer Biology and Therapeutics, Departments of Surgery, Cedars-Sinai Medical Center, Los Angeles, CA, 90048, USA.

Ju Dong Yang (JD)

Comprehensive Transplant Center, Cedars-Sinai Medical Center, Los Angeles, CA, 90048, USA.
Division of Digestive and Liver Diseases, Cedars Sinai Medical Center, Los Angeles, CA, 90048, USA.

Renjun Pei (R)

Key Laboratory for Nano-Bio Interface, Suzhou Institute of Nano-Tech and Nano-Bionics, University of Chinese Academy of Sciences, Chinese Academy of Sciences, 215123, Suzhou, P.R. China. rjpei2011@sinano.ac.cn.

Vatche G Agopian (VG)

Department of Surgery, David Geffen School of Medicine, University of California, Los Angeles, CA, 90095, USA. vagopian@mednet.ucla.edu.
Jonsson Comprehensive Cancer Center, University of California, Los Angeles, CA, 90095, USA. vagopian@mednet.ucla.edu.

Hsian-Rong Tseng (HR)

California NanoSystems Institute, Crump Institute for Molecular Imaging, Department of Molecular and Medical Pharmacology, University of California, Los Angeles, CA, 90095, USA. hrtseng@mednet.ucla.edu.
Jonsson Comprehensive Cancer Center, University of California, Los Angeles, CA, 90095, USA. hrtseng@mednet.ucla.edu.

Yazhen Zhu (Y)

California NanoSystems Institute, Crump Institute for Molecular Imaging, Department of Molecular and Medical Pharmacology, University of California, Los Angeles, CA, 90095, USA. yazhenzhu@mednet.ucla.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH